Suppression of human pancreatic cancer growth in BALB/c nude mice by manumycin, a farnesyl:protein transferase inhibitor

Japanese Journal of Cancer Research

Volumn 87, Issue 2, 1996, Pages 113-116

  Ito, Toshio ^a   Kawata, Sumio ^a   Tamura, Shinji ^a   Igura, Takumi ^a   Nagase, Toshihiko ^a   Miyagawa, Jun Ichiro ^a   Yamazaki, Eiji ^a   Ishiguro, Hiroshi ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Farnesyl:protein transferase inhibitor; Manumycin; Nude mouse; Pancreatic cancer; Ras

Indexed keywords

BROXURIDINE; MANUMYCIN; RAS PROTEIN; TRANSFERASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; GENE MUTATION; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE RAS; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN MODIFICATION;

EID: 0029877708     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb03146.x     Document Type: Article

References (15)

1. Barbacid, M. ras genes. Annu. Rev. Biochem., 56, 779-829 (1987).
2. Der, C. J. and Cox, A. D. Isoprenoid modification and plasma membrane association: critical factors for ras oncogenicity. Cancer Cells, 3, 331-337 (1991).
3. ras farnesyl:protein transferase by Cys-AAX tetrapeptides. Cell, 62, 81-88 (1990).
4. Schaber, M. D., O'Hara, M. B., Grarsky, V. M., Mosser, S. D., Bergstrom, J. D., Moores, S. L., Marshall, M. S., Friedman, P. A., Dixon, R. A. F. and Gibbs, J. B. Polyisoprenylation of Ras in vitro by a farnesyl-protein transferase. J. Biol. Chem., 265, 14701-14704 (1990).
5. Gibbs, J. B. Ras C-terminal processing enzymes - new drug targets? Cell, 65, 1-4 (1991).
6. Kawata, S., Kakimoto, H., Ishiguro, H., Yamasaki, E., Inui, Y. and Matsuzawa, Y. Effect of pravastatin, a potent 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, on survival of AH 130 hepatoma-bearing rats. Jpn. J. Cancer Res., 83, 1120-1123 (1992).
7. Kawata, S., Nagase, T., Yamasaki, E., Ishiguro, H. and Matsuzawa, Y. Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2). Br. J. Cancer, 69, 1015-1020 (1994).
8. Ruch, R. J. and Sigler, K. Growth inhibition of rat liver epithelial tumor cells by monoterpenes does not involve Ras plasma membrane association. Carcinogenesis, 15, 787-789 (1994).
9. Kohl, N. E., Mosser, S. D., de Solms, S. J., Giuliani, E. A., Pompliano, D. L., Graham, S. L., Smith, R. L., Scolnik, E. M., Oliff, A. and Gibbs, J. B. Selective inhibitors of ras-dependent transformation by a farnesyl-transferase inhibitor. Science, 260, 1934-1937 (1993).
10. James, G. L., Goldstein, J. L., Brown, M. S., Rawson, T. E., Somers, T. C., McDowell, R. S.; Crowley, C. W., Lucas, B. K., Levinson, A. D. and Marster, J. C., Jr. Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. Science, 260, 1937-1942 (1993).
11. Hara, M., Akasaka, K., Akinaga, S., Okabe, M., Nakano, H., Gomez, R., Wood, D., Uh, M. and Tamanoi, F. Identification of Ras farnesyltransferase inhibitors by microbial screening. Proc. Natl. Acad. Sci. USA, 90, 2281-2285 (1993).
12. Gibbs, J. B., Pompliano, D. L., Mosser, S. D., Rands, E., Lingham, R. B., Singh, S. B., Scolnick, E. M., Kohl, N. E. and Oliff, A. Selective inhibitor of farnesyl-protein transferase blocks ras processing in vivo. J. Biol. Chem., 268, 7617-7620 (1993).
13. Omura, S., Van Der Pyl, D., Inokoshi, J., Takahashi, Y. and Takeshima, H. Pepticinnamins, new farnesyl-protein transferase inhibitors produced by an actinomycete. I. Producing strain, fermentation, isolation and biological activity. J. Antibiot., 46, 222-228 (1993).
14. Yunis, A. A., Arimura, G. K. and Russin, D. J. Human pancreatic carcinoma MIA PaCa-2 in continuous culture: sensitivity to asparaginase. Int. J. Cancer, 19, 128-135 (1977).
15. Quaife, C. J., Pinkert, C. A., Ornitz, D. M., Palmiter, R. D. and Brinster, R. L. Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice. Cell, 48, 1023-1034 (1987).